TNFSF10 and neoplasm: The data revealed that Ad-TRAIL-MRE-1-133-218 had acomparative tumor-suppressing capacity on T24 and RT-4 bladder cancer cells aswell as primary bladder carcinoma cells with Ad-TRAIL (Figure 3c).